RUSSO, PAOLA ROSA NICE MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.166
AS - Asia 782
EU - Europa 658
SA - Sud America 106
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 3
Totale 2.790
Nazione #
US - Stati Uniti d'America 1.135
CN - Cina 428
SG - Singapore 171
IE - Irlanda 167
FI - Finlandia 101
BR - Brasile 83
DE - Germania 73
HK - Hong Kong 70
UA - Ucraina 70
RU - Federazione Russa 68
VN - Vietnam 49
IT - Italia 39
FR - Francia 37
ZA - Sudafrica 32
GB - Regno Unito 25
SE - Svezia 21
CA - Canada 14
AR - Argentina 12
BE - Belgio 12
IN - India 12
IQ - Iraq 12
PL - Polonia 12
ES - Italia 10
BD - Bangladesh 9
MX - Messico 9
PK - Pakistan 6
TR - Turchia 6
NL - Olanda 5
AT - Austria 3
JM - Giamaica 3
JP - Giappone 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GA - Gabon 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
ME - Montenegro 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
Totale 2.758
Città #
Dublin 167
Chandler 151
San Jose 123
Nanjing 100
Jacksonville 99
Ashburn 91
Singapore 90
Beijing 81
Hong Kong 68
Dallas 60
Boardman 58
Helsinki 46
Ann Arbor 43
Council Bluffs 36
Nanchang 36
Johannesburg 30
Princeton 27
Shenyang 27
Wilmington 26
Lawrence 25
Lauterbourg 24
Changsha 23
Los Angeles 23
Medford 23
Jiaxing 19
Hebei 17
Hangzhou 15
Ho Chi Minh City 15
Hanoi 14
Buffalo 13
Brussels 12
Moscow 11
Santa Clara 11
São Paulo 11
Tianjin 11
Woodbridge 11
Milan 10
New York 10
Warsaw 9
Redondo Beach 8
Shanghai 8
Stockholm 8
Montreal 7
Norwalk 7
London 6
Munich 6
Brooklyn 5
Verona 5
Baghdad 4
Bari 4
Charlotte 4
Columbus 4
Madrid 4
Mexico City 4
Orem 4
Pavia 4
Richmond 4
Toronto 4
Boston 3
Chennai 3
Chicago 3
Da Nang 3
Des Moines 3
Falkenstein 3
Guangzhou 3
Guarulhos 3
Houston 3
Hải Dương 3
Phoenix 3
Poplar 3
Rio de Janeiro 3
San Francisco 3
Seattle 3
Tokyo 3
Turku 3
Amsterdam 2
Atlanta 2
Berlin 2
Bratislava 2
Buenos Aires 2
Cairo 2
Cape Town 2
Changchun 2
Denver 2
Faisalabad 2
Fortaleza 2
Frankfurt am Main 2
Latisana 2
Libreville 2
Manchester 2
Memphis 2
Montevideo 2
Mumbai 2
Ningbo 2
Nuremberg 2
Paranavaí 2
Piscataway 2
Redwood City 2
Salvador 2
São Gonçalo 2
Totale 1.867
Nome #
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 158
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. 140
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 133
Reasoning with Effects of Clinical Guideline Actions Using OWL: AL Amyloidosis as a Case StudyKnowledge Representation for Health-Care 130
G-quest: a single platform for delivering questionnaires, educational material, and checklists on mobile devices 128
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 118
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine 117
A system for the extraction and representation of summary of product characteristics content. 117
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib and thalidomide 114
Correlation between serum concentrations of N-terminal natriuretic peptide type B (NT-proBNP) and troponin-I (TnI) in AL amyloidosis 113
AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical Entity 113
Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study. 110
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 109
AMICA: an electronic patient record specifically designed for an amyloidosis network. 109
Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis 107
Delivering and assessing learning material through Gquest: A case study on patient education 107
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 105
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis 104
A workflow management system for the biological samples exchange within the amyloidosis network 99
Developing an eLearning tool formalizing in YAWL the guidelines used in a transfusion medicine service. 93
Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib and dexamethasone 90
Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients 90
Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits 81
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. 77
The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients 65
The workings of the amyloid diseases. 63
Totale 2.790
Categoria #
all - tutte 12.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022103 0 0 0 4 3 0 2 12 5 5 17 55
2022/2023448 62 49 4 25 43 41 3 21 185 1 9 5
2023/2024146 26 40 5 5 16 27 1 13 3 5 1 4
2024/2025348 14 30 12 8 4 12 4 16 101 6 55 86
2025/2026925 72 60 113 106 140 53 143 46 76 52 12 52
2026/2027126 21 42 50 13 0 0 0 0 0 0 0 0
Totale 2.790